MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

Search

NeoGenomics Inc

Затворен

9.16 1.78

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

8.97

Максимум

9.45

Ключови измерители

By Trading Economics

Приходи

-19M

-45M

Продажби

13M

181M

Марж на печалбата

-24.867

Служители

2,200

EBITDA

-41M

-48M

Препоръки

By TipRanks

Препоръки

Купи

12-месечна прогноза

+18.16% upside

Дивиденти

By Dow Jones

Следващи печалби

28.10.2025 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

344M

1.2B

Предишно отваряне

7.38

Предишно затваряне

9.16

Техническа оценка

By Trading Central

Увереност

Very Strong Bearish Evidence

NeoGenomics Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

30.09.2025 г., 14:35 ч. UTC

Значими двигатели на пазара

Robo.ai Shares Rise After $300 Million Investment From Burkhan Capital

7.10.2025 г., 15:15 ч. UTC

Пазарно говорене

Investors Look to Gold, Bitcoin as Traditional Correlations Break Down -- Market Talk

7.10.2025 г., 12:33 ч. UTC

Придобивния, сливания и поглъщания

NYSE Owner to Invest Up to $2 Billion in Polymarket -- WSJ

7.10.2025 г., 12:32 ч. UTC

Придобивния, сливания и поглъщания

NYSE Owner to Invest Up to $2 Billion in Polymarket -- WSJ

7.10.2025 г., 11:53 ч. UTC

Пазарно говорене

Central Banks Could Add Bitcoin to Reserves -- Market Talk

7.10.2025 г., 08:20 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

7.10.2025 г., 07:00 ч. UTC

Пазарно говорене

Bitcoin Eases After Hitting Fresh Record High -- Market Talk

6.10.2025 г., 10:14 ч. UTC

Пазарно говорене

Bitcoin Could Extend Gains on U.S. Government Shutdown -- Market Talk

6.10.2025 г., 07:18 ч. UTC

Пазарно говорене

Market Talk Roundup: Latest on U.S. Politics

6.10.2025 г., 07:18 ч. UTC

Пазарно говорене

Bitcoin Stays Stronger After Hitting Record High -- Market Talk

3.10.2025 г., 13:10 ч. UTC

Пазарно говорене

Bitcoin Looks Ripe For Fresh Record High -- Market Talk

3.10.2025 г., 07:20 ч. UTC

Пазарно говорене

Bitcoin Pulls Back as Government Shutdown Delays Key Data -- Market Talk

2.10.2025 г., 13:17 ч. UTC

Придобивния, сливания и поглъщания

Bitcoin Depot: Acquisition Had No Material Impact on Reported 3Q Preliminary Results >BTM

2.10.2025 г., 13:16 ч. UTC

Придобивния, сливания и поглъщания

Bitcoin Depot: Acquisition Brings U.S. Market Share to Roughly 30% >BTM

2.10.2025 г., 13:16 ч. UTC

Придобивния, сливания и поглъщания

Bitcoin Depot: Acquisition Adds Over 500 Kiosks to Network >BTM

2.10.2025 г., 13:15 ч. UTC

Придобивния, сливания и поглъщания

Bitcoin Depot Acquires Assets of National Bitcoin ATM, Significantly Expanding U.S. Footprint

2.10.2025 г., 07:05 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

2.10.2025 г., 07:05 ч. UTC

Пазарно говорене

Bitcoin Rises Following Wall Street Rally -- Market Talk

1.10.2025 г., 23:12 ч. UTC

Придобивния, сливания и поглъщания

Avalanche Treasury CEO is Bart Smith

1.10.2025 г., 23:11 ч. UTC

Придобивния, сливания и поглъщания

Avalanche Treasury Investors Include Dragonfly, VanEck, Galaxy Digital and Others

1.10.2025 г., 23:07 ч. UTC

Придобивния, сливания и поглъщания

Avalanche Treasury Plans to Own More Than $1B Worth of AVAX After Becoming a Public Company

1.10.2025 г., 23:06 ч. UTC

Придобивния, сливания и поглъщания

Avalanche Treasury Co. Has an Exclusive Relationship With Avalanche Foundation

1.10.2025 г., 23:04 ч. UTC

Придобивния, сливания и поглъщания

Avalanche Treasury: Transaction Includes About $460M in Treasury Assets

1.10.2025 г., 14:01 ч. UTC

Пазарно говорене

Bitcoin Rises as Weak Jobs Data Boost Rate-Cut Bets -- Market Talk

1.10.2025 г., 07:27 ч. UTC

Пазарно говорене

Bitcoin Edges Lower as U.S. Government Shut Down Begins -- Market Talk

30.09.2025 г., 14:20 ч. UTC

Значими двигатели на пазара

Robo.ai Shares Rise After $300M Investment From Burkhan Capital

30.09.2025 г., 06:51 ч. UTC

Пазарно говорене

Bitcoin Eases as Possible U.S. Government Shutdown Looms -- Market Talk

29.09.2025 г., 13:48 ч. UTC

Пазарно говорене

Seasonality Could Favor Bitcoin in Coming Months -- Market Talk

29.09.2025 г., 07:40 ч. UTC

Пазарно говорене

Bitcoin Recovers But Remains at Risk of Renewed Losses -- Market Talk

26.09.2025 г., 07:29 ч. UTC

Пазарно говорене

Bitcoin Stabilizes After Steep Falls; Focus Turns to U.S. PCE Data -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

NeoGenomics Inc Прогноза

Ценова цел

By TipRanks

18.16% нагоре

12-месечна прогноза

Среден 10.67 USD  18.16%

Висок 14 USD

Нисък 8 USD

Според 11 анализатори от Wall Street, предложили 12-месечна ценова цел за NeoGenomics Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

11 ratings

5

Купи

6

Задържане

0

Продай

Техническа оценка

By Trading Central

7.7 / 10.27Подкрепа & съпротива

Краткосрочен план

Very Strong Bearish Evidence

Средносрочен план

Bearish Evidence

Дългосрочен план

Bearish Evidence

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.
help-icon Live chat